# A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency

> **NCT07262333** · PHASE1 · RECRUITING · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 56 (estimated)

## Conditions studied

- Renal Insufficiency Chronic

## Interventions

- **DRUG:** Hydronidone capsules

## Key facts

- **NCT ID:** NCT07262333
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07262333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07262333, "A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07262333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*